Clinical Trial Update: A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions. [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a 2% cidofovir gel applied to the cervix for high-grade cervical intraepithelial neoplasia (CIN2+) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Cidofovir (cidofovir)

Snippet

Sponsor: Brugmann University Hospital | Conditions: High Grade Cervical Epithelial Neoplasia (CIN2+) | Phase 2 | Status: COMPLETED